Becker's Healthcare January 16, 2026
Francesca Mathewes

As ASC platforms settle into 2026, the next phase of value creation is coming into focus.

Two leaders in the ASC space recently joined Becker’s to share their visions for what will create growth for ASCs this year.

Editor’s note: Responses have been lightly edited for clarity and length.

Question: What do you see as ASCs’ biggest opportunity for growth in 2026?

Rhett Barker. CEO of AlloDirect: Here’s what I think is actually happening: The big rollups we saw in 2024 and 2025 bought scale and market position, but they didn’t necessarily buy supply-chain margin. Now those platforms are in the “second bite of the apple” phase, where the real value creation is in capturing procurement savings...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: ASC, Provider
The new age of ASC de novos
The ASC decisions that must stay in clinicians’ hands
ASC and payers’ ‘game of chicken’
NueHealth’s ASC growth play, decoded
Why clinical leadership is a must for ASC success

Share Article